Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Atomekon Feb 04, 2016 9:56am

147 Views

Post# 24523555

Short Positions for PLI

Symbol	Report Date	Volume	Change	Shares Issued	% Float
T : PLI	2016-01-31	2,694,496	304,095	581,930,868	0.46
T : PLI	2016-01-15	2,390,401	-856,103	581,930,868	0.41
T : PLI	2015-12-31	3,246,504	9,976	581,096,572	0.56
T : PLI	2015-12-15	3,236,528	-1,610,662	581,096,572	0.56
T : PLI	2015-11-30	4,847,190	-164,762	581,096,572	0.83
T : PLI	2015-11-15	5,011,952	-347,572	581,013,984	0.86
T : PLI	2015-10-31	5,359,524	118,366	581,013,609	0.92